MEDIFAST (MED)
(Delayed Data from NYSE)
$25.74 USD
-0.36 (-1.38%)
Updated May 31, 2024 04:00 PM ET
After-Market: $25.74 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$25.74 USD
-0.36 (-1.38%)
Updated May 31, 2024 04:00 PM ET
After-Market: $25.74 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Zacks News
Dean Foods Dips to a 52-Week Low, Input Costs a Key Concern
by Zacks Equity Research
Dean Foods (DF) is fighting obstacles related to input cost inflation, tepid volumes and higher retailer investments in the private label space, weighing on its performance.
Campbell (CPB) Sees Soft Q4 Earnings, Unveils Strategic Plans
by Zacks Equity Research
Campbell's (CPB) earnings fall due to higher tax rate, lower adjusted EBIT on base business and more. The company unveils various actions to improve business as part of strategic portfolio review.
Hain Celestial (HAIN) Q4 Earnings Decline Y/Y, Stock Down
by Zacks Equity Research
Hain Celestial (HAIN) witnesses the third straight quarter of sales miss in Q4. Also, high promotional and trade investments along with freight costs hurt gross margin.
Tyson Foods Down 10% in 3 Months, Market Volatility a Worry
by Zacks Equity Research
Tyson Foods' (TSN) Chicken and Pork segment witness unstable market conditions stemming from increased tariffs.
Anatomy of Success: Medifast Inc. (MED)
by Madeleine Johnson
This Zacks Rank #1 stock skyrocketed over +130% in just six months.
Sanderson Farms (SAFM) Q3 Earnings & Sales Fall Year on Year
by Zacks Equity Research
Sanderson Farms' (SAFM) Q3 results are negatively impacted by lower average selling prices and increased costs of sales.
Hormel Foods (HRL) Stock Down 5% Despite Q3 Earnings Beat
by Zacks Equity Research
Hormel Foods' (HRL) top and bottom lines improve year over year in Q3. However, sales lag estimate and management cuts sales outlook.
Hershey Up More Than 10% in 3 Months: More Room for Growth?
by Zacks Equity Research
Hershey (HSY) is gaining from its buyout of Amplify, focus on productivity improvements and brand strength. However, escalated costs remain a threat to margins.
Clorox (CLX) Surges 24% in 3 Months: More Room to Run?
by Zacks Equity Research
Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
Can Dean Foods' Cost-Cutting Plans Provide Respite to Stock?
by Zacks Equity Research
Dean Foods (DF) has been taking steps to reduce unnecessary costs and improve efficiency. These initiatives should help offset some negative impacts from volume declines and higher input costs.
Archer Daniels (ADM) Up 26% YTD: Will the Momentum Continue?
by Zacks Equity Research
Archer Daniels (ADM) looks promising backed by cost-savings efforts and management of its business portfolio. The company has an impressive earnings surprise trend as well.
Buy These 5 Low-Beta Stocks to Brave Market Volatility
by Zacks Equity Research
In this article, we have come up with an investment strategy that clearly shows that less risky securities can also generate handsome returns if some parameters are considered.
Helen of Troy Up Post Q1: Earnings Beat Not the Sole Factor
by Zacks Equity Research
Helen of Troy (HELE) has been gaining from its consistent online sales and digital marketing efforts. Strength in Leadership Brands and Project Refuel has also been driving performance.
Church & Dwight (CHD) Up 20% in 3 Months: More Room to Run?
by Zacks Equity Research
The company has outpaced the industry in the past three months, gaining from its focus on buyouts, robust international business and innovations.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Sysco (SYY) Looks Good: Stock Adds 6.2% in Session
by Zacks Equity Research
Sysco (SYY) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Tyson Foods' (TSN) Sale of Pizza Crust Unit to Drive Growth
by Zacks Equity Research
Tyson Foods (TSN) inks a deal to offload its pizza crust business to an affiliate of Peak Rock Capital. The agreement, which includes the sale of TNT Crust, is expected to close in September.
Flowers Foods (FLO) Stock Down on Q2 Earnings Miss, View Cut
by Zacks Equity Research
Flowers Foods' (FLO) Q2 sales remain strong but earnings fall short of the Zacks Consensus Estimate owing to factors that weighed on margins.
5 Top Momentum Stocks Powered by Driehaus Strategy
by Zacks Equity Research
Richard Herman Driehaus who is a well-known American businessman and fund manager, developed an investment approach based on the buy high and sell higher rule.
Aramark (ARMK) Surges: Stock Moves 7.2% Higher
by Zacks Equity Research
Aramark (ARMK) shares rose more than 7% in the last trading session, amid huge volumes.
Dean Foods (DF) Tumbles 15% Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Dean Foods' (DF) top and bottom lines beat estimates and sales increase year over year in Q2. However, non-dairy inflation and private label competition lead to a view cut.
New Strong Buy Stocks for August 8th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
CHEF vs. MED: Which Stock Is the Better Value Option?
by Zacks Equity Research
CHEF vs. MED: Which Stock Is the Better Value Option?
Medifast (MED) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 16.00% and 15.48%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?